Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT05141539
Other study ID # COA. MURA2021/73
Secondary ID
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date February 1, 2021
Est. completion date September 30, 2023

Study information

Verified date February 2023
Source Mahidol University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The current cervical range of motion (CROM) and tongue movement measurement methods are not reliable between observers, which is not practical in real-world usage. This research is to develop the cervical range of motion measurement, and tongue movement estimation software, to compare between the developed software and the current measurement techniques, and to test in clinical aspects for reliability and validity assessment. The investigators investigate the developed software in healthy people in phase 1. In phases 2 and 3, the investigators compare the software to the standard measurement methods in dysphagic patients who have head and neck cancer for reliability and validity.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 88
Est. completion date September 30, 2023
Est. primary completion date June 30, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria in Phase 2 - Occupational therapist 1. This study requires the subject to be between 18 and 80 years old. 2. The subject needs to be Thai. 3. The subject can communicate in the Thai language. 4. Working as an occupational therapist in Ramathibodhi hospital. 5. The subject is consent. - Head and neck cancer patients 1. This study requires the subject to be between 18 and 80 years old. 2. The subject needs to have stable vital signs. 3. The subject can make the body steady sit on the chair longer than 30 minutes. 4. The subject is diagnosed with head and neck cancer and treated at Ramathibodhi hospital. 5. Eating Assessment Tool (EAT-10) score is more than or equals 3. 6. Montreal Cognitive Assessment (MOCA) score is more than or equals 23. 7. The subject is consent. Exclusion Criteria in Phase 2 - Occupational therapist 1. Cannot participate in the experiment. 2. The therapist denied or withdrew. - Head and neck cancer patients 1. Have pain around the examination area such as oral mucosa, tongue, and neck. 2. Participate in chemotherapy. 3. Cannot participant until the end of the experiment. 4. The subject denied or withdrew. Inclusion Criteria in Phase 3 - Dysphagic Specialist 1. The age is more than 18 years old. 2. The specialist is required to be Thai. 3. The specialist can communicate in the Thai language. 4. Working in oropharyngeal swallowing rehabilitation in the dysphagic unit at Ramathibodhi hospital for more than 3 years. 5. The specialist has papers related to swallowing rehabilitation. 6. The specialist is consent. - Observers 1. This study requires the subject to be between 18 and 80 years old. 2. The observer can communicate in the Thai language. 3. The observer needs to be Thai. 4. Working in swallowing rehabilitation in Ramathibodhi hospital for more than a year. 5. The observer is consent. - Head and neck cancer patients The criteria are the same as the inclusion criteria of head and neck cancer patients in phase 2. Exclusion Criteria in Phase 3 - Dysphagic Specialist 1. Cannot participant in the experiment. 2. The specialist denied or withdrew. - Observers 1. Have a relationship with software development. 2. Cannot participate in the study until the end of the experiment. 3. The subject denied or withdrew. - Head and neck cancer patients The criteria are the same as the exclusion criteria of head and neck cancer patients in phase 2.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Rehabilitation assessment software
In phase 2, this software will be tested in occupational therapists, and head and neck cancer patients results for reliability and validity. In phase 3, the experiment in the oropharyngeal dysphagia specialists results in content validity, the comparison between the developed software, and VFSS and FOIS results in criterion-related validity, and the experiment in head and neck cancer patients results in reliability.
VFSS and FOIS
In phase 3, this study applies VFSS and FOIS for the head and neck cancer patients for comparison with the developed rehabilitation assessment software for criterion-related validity.

Locations

Country Name City State
Thailand Department of Rehabilitation Medicine, Ramathibodhi Hospital Phaya Thai Bangkok

Sponsors (1)

Lead Sponsor Collaborator
Mahidol University

Country where clinical trial is conducted

Thailand, 

Outcome

Type Measure Description Time frame Safety issue
Primary Intra-rater reliability between the developed rehabilitation assessment software and the standard CROM measurement method. The same investigator will repeat cervical range of motion measurement by using the developed rehabilitation software and the standard cervical range of motion (CROM) measurement method from the goniometer. One hour
Primary Inter-rater reliability between the developed rehabilitation assessment software and the standard CROM measurement method. The cervical range of motion (CROM) measurement by using the developed rehabilitation software and the standard CROM measurement method from the goniometer will be repeated by different observers. One hour
Primary Concurrent measurement validity between the developed rehabilitation assessment software and the standard CROM measurement method. The correlation of the concurrent cervical range of motion (CROM) measurement outcome at approximately the same time between the developed rehabilitation assessment software and the standard CROM measurement method from the goniometer. One hour
Primary Criterion-related validity between the developed rehabilitation assessment software, and VFSS and FOIS. The criterion-related validity of the rehabilitation assessment software will be assessed by the correlation between the cervical range of motion measurement by the developed rehabilitation assessment software and the functional swallowing assessment by videofluoroscopic Swallowing Study (VFSS), and functional oral intake scale (FOIS). One month
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1